Weighing risks and benefits of liraglutide--the FDA's review of a new antidiabetic therapy (Q34616881)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Weighing risks and benefits of liraglutide--the FDA's review of a new antidiabetic therapy |
scientific article |
Statements
1 reference
Weighing risks and benefits of liraglutide--the FDA's review of a new antidiabetic therapy (English)
1 reference
Mary Parks
1 reference
Curtis Rosebraugh
1 reference
17 February 2010
1 reference
1 reference
Identifiers
1 reference